Literature DB >> 11792724

A synthetic low density lipoprotein particle capable of supporting U937 proliferation in vitro.

G Baillie1, M D Owens, G W Halbert.   

Abstract

A synthetic LDL (sLDL) has been prepared by combining a lipid microemulsion with amphipathic peptides containing the apoprotein B receptor domain. The biological properties of sLDL have been investigated using the U937 in vitro cell proliferation assay. sLDL exhibits a concentration dependent and saturable stimulation of U937 proliferation. By utilizing different amphipathic peptides, variable proliferation is achieved, indicating a specific interaction between sLDL and the U937 LDL receptor are possible. U937 proliferation is reduced by the addition of an anti-LDL receptor antibody, indicating that sLDL is assimilated via the LDL receptor pathway. The behavior of sLDL mimics that of native LDL, and this approach represents a viable technique for the production of an sLDL particle on a large scale for research and general application.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792724

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

Review 1.  Learning from biology: synthetic lipoproteins for drug delivery.

Authors:  Huang Huang; William Cruz; Juan Chen; Gang Zheng
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-10-24

2.  Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.

Authors:  Junyi Qian; Ningze Xu; Xu Zhou; Kaihong Shi; Qian Du; Xiaoxing Yin; Ziming Zhao
Journal:  Int J Nanomedicine       Date:  2019-09-11

3.  Low Density Lipid Nanoparticles for Solid Tumor Targeting.

Authors:  Mayank Shrivastava; Aviral Jain; Arvind Gulbake; Pooja Hurkat; Neeti Jain; R Vijayraghwan; Sanjay K Jain
Journal:  Sci Pharm       Date:  2014-08-28

4.  Synthetic low-density lipoprotein (sLDL) selectively delivers paclitaxel to tumor with low systemic toxicity.

Authors:  Hai-Tao Su; Xin Li; De-Sheng Liang; Xian-Rong Qi
Journal:  Oncotarget       Date:  2016-08-09

Review 5.  Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.

Authors:  Gunter Almer; Harald Mangge; Andreas Zimmer; Ruth Prassl
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 6.  Reconfiguring Nature's Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents.

Authors:  Skylar T Chuang; Siobanth Cruz; Vasanthy Narayanaswami
Journal:  Nanomaterials (Basel)       Date:  2020-05-08       Impact factor: 5.076

7.  LDL-mimetic lipid nanoparticles prepared by surface KAT ligation for in vivo MRI of atherosclerosis.

Authors:  Alessandro Fracassi; Jianbo Cao; Naoko Yoshizawa-Sugata; Éva Tóth; Corey Archer; Olivier Gröninger; Emanuela Ricciotti; Soon Yew Tang; Stephan Handschin; Jean-Pascal Bourgeois; Ankita Ray; Korinne Liosi; Sean Oriana; Wendelin Stark; Hisao Masai; Rong Zhou; Yoko Yamakoshi
Journal:  Chem Sci       Date:  2020-10-07       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.